PROPHYLACTIC ERGOMETRIN VERSUS OXYTOCIN IN THIRD STAGE
Not Applicable
- Conditions
- Pregnancy and ChildbirthPOST PARTUM HAEMORRHAGE
- Registration Number
- PACTR201105000292708
- Lead Sponsor
- DR EZEAMA C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 600
Inclusion Criteria
Consenting women
Women who had vaginal delivery
Exclusion Criteria
Refusal of consent
Women that had Caesarean Section
Women with Antepartum haemorrhage.
Women with Pregnancy induced hypertension, chronic hypertension, eclampsia or cardiac disease in pregnancy.
Women with severe anaemia in pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Measured blood loss >500 mls after intervention. 2. Side effects (Headache, vomiting, increased diastolic hypertension) within 30 minutes of intervention.
- Secondary Outcome Measures
Name Time Method 1. Blood Transfusion 2. Additional Uterotonic agent after enrolment 3. Manual Removal of Placenta 4. Evacuation of retained products of conception 5. Hysterectomy 6. Maternal Death